1134 related articles for article (PubMed ID: 35293087)
1. Dronedarone for the treatment of atrial fibrillation with concomitant heart failure with preserved and mildly reduced ejection fraction: a post-hoc analysis of the ATHENA trial.
Vaduganathan M; Piccini JP; Camm AJ; Crijns HJGM; Anker SD; Butler J; Stewart J; Braceras R; Albuquerque APA; Wieloch M; Hohnloser SH
Eur J Heart Fail; 2022 Jun; 24(6):1094-1101. PubMed ID: 35293087
[TBL] [Abstract][Full Text] [Related]
2. Atrial fibrillation and risk of adverse outcomes in heart failure with reduced, mildly reduced, and preserved ejection fraction: A systematic review and meta-analysis.
Kroshian G; Joseph J; Kinlay S; Peralta AO; Hoffmeister PS; Singh JP; Yuyun MF
J Cardiovasc Electrophysiol; 2024 Apr; 35(4):715-726. PubMed ID: 38348517
[TBL] [Abstract][Full Text] [Related]
3. Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.
Sartipy U; Dahlström U; Fu M; Lund LH
JACC Heart Fail; 2017 Aug; 5(8):565-574. PubMed ID: 28711451
[TBL] [Abstract][Full Text] [Related]
4. Predictors and prognostic implications of left ventricular ejection fraction trajectory improvement in the spectrum of heart failure with reduced and mildly reduced ejection fraction.
Si J; Ding Z; Hu Y; Zhang X; Zhang Y; Cao H; Liu Y
J Cardiol; 2024 Apr; 83(4):250-257. PubMed ID: 37802201
[TBL] [Abstract][Full Text] [Related]
5. Effect of digoxin in patients with heart failure and mid-range (borderline) left ventricular ejection fraction.
Abdul-Rahim AH; Shen L; Rush CJ; Jhund PS; Lees KR; McMurray JJV;
Eur J Heart Fail; 2018 Jul; 20(7):1139-1145. PubMed ID: 29493058
[TBL] [Abstract][Full Text] [Related]
6. Cryoballoon ablation for atrial fibrillation in patients with heart failure with mildly reduced and preserved ejection fraction.
Chen C; Cheng K; Gao X; Zou T; Pang Y; Ling Y; Xu Y; Xu Y; Chen Q; Zhu W; Ge J
ESC Heart Fail; 2023 Feb; 10(1):518-531. PubMed ID: 36325978
[TBL] [Abstract][Full Text] [Related]
7. [Contemporary epidemiology and treatment of hospitalized heart failure patients in real clinical practice in China].
Wang H; Li YY; Chai K; Zhang W; Li XL; Dong YG; Zhou JM; Huo Y; Yang JF
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):865-874. PubMed ID: 31744275
[No Abstract] [Full Text] [Related]
8. Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction.
Son MK; Park JJ; Lim NK; Kim WH; Choi DJ
Heart; 2020 Aug; 106(15):1160-1168. PubMed ID: 32341140
[TBL] [Abstract][Full Text] [Related]
9. Heart failure and the risk of left atrial thrombus formation in patients with atrial fibrillation or atrial flutter.
Wybraniec MT; Mizia-Szubryt M; Cichoń M; Wrona-Kolasa K; Kapłon-Cieślicka A; Gawałko M; Budnik M; Uziębło-Życzkowska B; Krzesiński P; Starzyk K; Gorczyca-Głowacka I; Daniłowicz-Szymanowicz L; Kaufmann D; Wójcik M; Błaszczyk R; Hiczkiewicz J; Łojewska K; Kosmalska K; Fijałkowski M; Szymańska A; Wiktorska A; Haberka M; Kucio M; Michalski B; Kupczyńska K; Tomaszuk-Kazberuk A; Wilk-Śledziewska K; Wachnicka-Truty R; Koziński M; Burchardt P; Mizia-Stec K
ESC Heart Fail; 2022 Dec; 9(6):4064-4076. PubMed ID: 36039813
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan.
Shiga T; Suzuki A; Haruta S; Mori F; Ota Y; Yagi M; Oka T; Tanaka H; Murasaki S; Yamauchi T; Katoh J; Hattori H; Kikuchi N; Watanabe E; Yamada Y; Haruki S; Kogure T; Suzuki T; Uetsuka Y; Hagiwara N;
ESC Heart Fail; 2019 Jun; 6(3):475-486. PubMed ID: 30829002
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics, one-year change in ejection fraction and long-term outcomes in patients with heart failure with mid-range ejection fraction: a multicentre prospective observational study in Catalonia (Spain).
Farré N; Lupon J; Roig E; Gonzalez-Costello J; Vila J; Perez S; de Antonio M; Solé-González E; Sánchez-Enrique C; Moliner P; Ruiz S; Enjuanes C; Mirabet S; Bayés-Genís A; Comin-Colet J;
BMJ Open; 2017 Dec; 7(12):e018719. PubMed ID: 29273666
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Significance of New-Onset Atrial Fibrillation in Heart Failure with Preserved, Mid-Range, and Reduced Ejection Fraction Following Acute Myocardial Infarction: Data from the NOAFCAMI-SH Registry.
Hao C; Luo J; Liu B; Xu W; Li Z; Gong M; Qin X; Shi B; Wei Y
Clin Interv Aging; 2022; 17():479-493. PubMed ID: 35444413
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of dronedarone in patients with a prior ablation for atrial fibrillation/flutter: Insights from the ATHENA study.
Vamos M; Calkins H; Kowey PR; Torp-Pedersen CT; Corp Dit Genti V; Wieloch M; Koren A; Hohnloser SH
Clin Cardiol; 2020 Mar; 43(3):291-297. PubMed ID: 31872901
[TBL] [Abstract][Full Text] [Related]
14. Impact of left ventricular ejection fraction phenotypes on healthcare resource utilization in hospitalized heart failure: a secondary analysis of REPORT-HF.
Farmakis D; Tromp J; Marinaki S; Ouwerkerk W; Angermann CE; Bistola V; Dahlstrom U; Dickstein K; Ertl G; Ghadanfar M; Hassanein M; Obergfell A; Perrone SV; Polyzogopoulou E; Schweizer A; Boletis I; Cleland JGF; Collins SP; Lam CSP; Filippatos G
Eur J Heart Fail; 2023 Jun; 25(6):818-828. PubMed ID: 36974770
[TBL] [Abstract][Full Text] [Related]
15. Thromboembolisms in atrial fibrillation and heart failure patients with a preserved ejection fraction (HFpEF) compared to those with a reduced ejection fraction (HFrEF).
Sobue Y; Watanabe E; Lip GYH; Koshikawa M; Ichikawa T; Kawai M; Harada M; Inamasu J; Ozaki Y
Heart Vessels; 2018 Apr; 33(4):403-412. PubMed ID: 29067492
[TBL] [Abstract][Full Text] [Related]
16. Catheter ablation for non-paroxysmal atrial fibrillation accompanied by heart failure with preserved ejection fraction: feasibility and benefits in functions and B-type natriuretic peptide.
Yamauchi R; Morishima I; Okumura K; Kanzaki Y; Morita Y; Takagi K; Nagai H; Watanabe N; Furui K; Yoshioka N; Miyazawa H; Shimojo K; Imaoka T; Sakamoto G; Murohara T
Europace; 2021 Aug; 23(8):1252-1261. PubMed ID: 33693617
[TBL] [Abstract][Full Text] [Related]
17. A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction - insights from the ESC-HFA EORP Heart Failure Long-Term Registry.
Kapłon-Cieślicka A; Benson L; Chioncel O; Crespo-Leiro MG; Coats AJS; Anker SD; Filippatos G; Ruschitzka F; Hage C; Drożdż J; Seferovic P; Rosano GMC; Piepoli M; Mebazaa A; McDonagh T; Lainscak M; Savarese G; Ferrari R; Maggioni AP; Lund LH;
Eur J Heart Fail; 2022 Feb; 24(2):335-350. PubMed ID: 34962044
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of incident atrial fibrillation in heart failure with preserved or reduced ejection fraction: A community-based study.
Zhang P; Chamberlain AM; Hodge DO; Cai C; Xiao PL; Han J; Jiang CY; Redfield MM; Roger VL; Cha YM
J Cardiovasc Electrophysiol; 2020 Sep; 31(9):2275-2283. PubMed ID: 32584498
[TBL] [Abstract][Full Text] [Related]
19. Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome.
Farmakis D; Simitsis P; Bistola V; Triposkiadis F; Ikonomidis I; Katsanos S; Bakosis G; Hatziagelaki E; Lekakis J; Mebazaa A; Parissis J
Clin Res Cardiol; 2017 May; 106(5):359-368. PubMed ID: 27999929
[TBL] [Abstract][Full Text] [Related]
20. Five-year mortality of heart failure with preserved, mildly reduced, and reduced ejection fraction in a 4880 Chinese cohort.
Chen S; Huang Z; Liang Y; Zhao X; Aobuliksimu X; Wang B; He Y; Kang Y; Huang H; Li Q; Yao Y; Lu X; Qian X; Xie X; Liu J; Liu Y
ESC Heart Fail; 2022 Aug; 9(4):2336-2347. PubMed ID: 35437939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
